Women Health

A new study confirms that the 9-valent human papillomavirus (HPV) vaccine offers strong protection for women who undergo surgical treatment for precancerous cervical lesions. Researchers at the Comprehensive Cancer Centre…

Anabel Cano believed she was free of cancer after a routine mammogram in Andalusia, a region in southern Spain. But nearly a year later, she underwent a mastectomy and lost…

A new therapy for HER2-positive breast cancer is showing encouraging results in early clinical trials. The bispecific antibody-drug conjugate (ADC) TQB2102 demonstrated strong antitumor activity and a favorable safety profile…

A recent analysis has highlighted a previously overlooked hormone as a key driver of deadly breast cancer in postmenopausal women with obesity. The hormone, estrone, may explain why women with…

The World Health Organization (WHO) has officially endorsed the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss, while warning that access to these drugs may remain limited for…

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly prescribed to manage type 2 diabetes and obesity. However, these medications are not recommended during pregnancy. A recent study in JAMA Network…

Israeli digital-health startup YuviTal has been chosen to lead a new initiative aimed at improving care for women undergoing breast cancer treatment. The selection follows a joint competition organized by…

While the holidays are typically associated with family gatherings and celebrations, for plastic surgeons, it’s the busiest time of the year. Many patients rush to use remaining insurance benefits or…

Sierra Leone aims for a sharp decline in cervical cancer cases with the launch of a nationwide vaccination campaign targeting girls aged 11 to 18. “Cervical cancer is preventable, yet…

Australia’s national medicines regulator has issued a safety warning over a class of weight-loss and diabetes drugs linked to potential mental health risks. The Therapeutic Goods Administration (TGA) updated its…

Eli Lilly announced Monday that it has cut the price of its single-dose vials of Zepbound, its popular obesity drug, aiming to make the treatment more affordable amid rising demand…

Women who miss their first scheduled mammogram may face a 40% higher long-term risk of dying from breast cancer, according to a large Swedish study published in The BMJ. The…

Australia remains on track to eliminate cervical cancer as a public health problem, but declining HPV vaccination and cervical screening rates are emerging as major obstacles, according to the 2025…

Pregnancy with an intrauterine device (IUD) is rare but possible. According to the American College of Obstetricians and Gynecologists (ACOG), fewer than 1% of people using an IUD or implant…

A global review of more than 1.6 million pregnancies shows that most pregnant people gain either too little or too much weight, patterns linked to significant health risks for both…

A new review published in The BMJ reports no clear evidence that paracetamol use during pregnancy increases the risk of autism or attention-deficit/hyperactivity disorder (ADHD) in children. Researchers found that…

A new global review has identified wide geographical disparities in the availability and quality of clinical guidance for endometriosis, highlighting gaps that may contribute to delayed diagnosis and uneven access…

Canada’s efforts to eliminate cervical cancer have stalled, according to a new report that warns the country’s decades-long progress toward ending the disease is losing momentum. The 2025 Canadian Cancer…

Breast cancer remains a leading cause of cancer death among women worldwide, particularly in low-resource regions where access to advanced diagnostics is limited. Emerging research highlights the growing role of…

A recent systematic review suggests that indocyanine green (ICG) may be an effective, less invasive option for detecting vulvar cancer, comparable to traditional tracers such as technetium-99m (Tc-99m) and blue…